Showing results (21-30 of 86) with videos related to
Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|November 26, 2015
Pharmacodynamic modeling of combined chemotherapeutic effects predicts synergistic activity of gemcitabine and trabectedin in pancreatic cancer cellsXin Miao, Gilbert Koch, Robert M Straubinger, et al.Journal of Chromatography. A|October 7, 2008
Ultra-sensitive quantification of paclitaxel using selective solid-phase extraction in conjunction with reversed-phase capillary liquid chromatography/tandem mass spectrometryHaoying Yu, Robert M Straubinger, Jin Cao, et al.Journal of Materials Chemistry. B|January 14, 2025
Magnetic chromatography improves colloidal and MRI attributes of magnetoliposomes enabling evaluation of the impact of size on bio-distribution in an in vivo model of pancreatic cancerCara Moloney, Tista Roy Chaudhuri, Robert M Straubinger, et al.Journal of Proteome Research|October 31, 2023
Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces Cancer Cell Death via Metabolic Remodeling and Activation of the Extrinsic Apoptosis PathwaySailee Rasam, Qingxiang Lin, Shichen Shen, et al.The Analyst|December 17, 2008
Highly selective and sensitive assay for paclitaxel accumulation by tumor cells based on selective solid phase extraction and micro-flow liquid chromatography coupled to mass spectrometryJulio R Gaspar, Jun Qu, Ninfa L Straubinger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor modelRobert D Arnold, Donald E Mager, Jeanine E Slack, et al.BMC Cancer|October 24, 2020
Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cellsJin Niu, Xue Wang, Jun Qu, et al.Frontiers in Pharmacology|March 10, 2018
Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer CellsXu Zhu, Xiaomeng Shen, Jun Qu, et al.CPT: Pharmacometrics & Systems Pharmacology|August 8, 2018
Multi-Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer CellsXu Zhu, Xiaomeng Shen, Jun Qu, et al.Anticancer Research|May 22, 2004
Antivascular and antitumor activities of liposome-associated drugsRobert M Straubinger, Robert D Arnold, Rong Zhou, et al.Pageof 9